24.01.07 Budapest. New GMO rules established in early December by the Hungarian government have been sharply criticised by the biotech sector. The industry is especially concerned about a modification to to Act XXVII/1998 on genetic...
more
24.01.07 Budapest – The corporate finance advisory firm PCA in collaboration with the Hungarian Biotechnology Association (HBA) have published a comprehensive industry report entitled ‘Biotechnology in Hungary 2006 – Unfolding...
more
21.11.06 Zagreb – Consolidation of the generic-drug business is focusing on eastern Europe. So far in 2006, at least eight deals have been announced, including Barr Pharmaceuticals‘ US$2.5-billion acquisition of Croatia‘s Pliva, completed...
more
21.11.06 Gödöllö – At the end of September, GlaxoSmithKline (GSK) inaugurated a new a100-million vaccine production plant 30 km northeast of the Hungarian capital.According to GSK, the new facility will be one of Europe’s most advanced...
more
21.07.06 Zagreb – In the bidding race between the Icelandic Actavis Group and US Barr Pharmaceuticals Inc. for the takeover of the Croatian biogenerics producer Pliva d.d., the company ultimately opted for Barr’s offer. Both companies’...
more
